AstraZeneca Gets CDSCO Approvals For Liver Cancer Drug in India

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has authorised AstraZeneca Pharma India’s Tremelimumab Concentrate for intravenous administration, the